ATE547122T1 - Zusammensetzung zur stabilisierung von hyaluronsäure - Google Patents

Zusammensetzung zur stabilisierung von hyaluronsäure

Info

Publication number: ATE547122T1
Authority: AT; Austria
Prior art keywords: hyaluronic acid; compositions; composition; stabilizing; stabilizing hyaluronic
Prior art date: 2001-11-21

Application number

AT02795068T

Other languages

English (en)

Inventor

Fu-Pao Tsao

Original Assignee

Novartis Pharma Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-11-21

Filing date

2002-11-20

Publication date

2012-03-15

2002-11-20 Application filed by Novartis Pharma Gmbh filed Critical Novartis Pharma Gmbh

2012-03-15 Application granted granted Critical

2012-03-15 Publication of ATE547122T1 publication Critical patent/ATE547122T1/de

Links

239000000203 mixture Substances 0.000 title abstract 5
KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title abstract 3
229920002674 hyaluronan Polymers 0.000 title abstract 3
229960003160 hyaluronic acid Drugs 0.000 title abstract 3
230000000087 stabilizing effect Effects 0.000 title 1
238000000034 method Methods 0.000 abstract 2
239000002738 chelating agent Substances 0.000 abstract 1
238000000354 decomposition reaction Methods 0.000 abstract 1
DUYCTCQXNHFCSJ-UHFFFAOYSA-N dtpmp Chemical compound OP(=O)(O)CN(CP(O)(O)=O)CCN(CP(O)(=O)O)CCN(CP(O)(O)=O)CP(O)(O)=O DUYCTCQXNHFCSJ-UHFFFAOYSA-N 0.000 abstract 1
239000000463 material Substances 0.000 abstract 1
150000002903 organophosphorus compounds Chemical class 0.000 abstract 1
-1 poly(carboxylic acids) Polymers 0.000 abstract 1
238000001356 surgical procedure Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/08—Mydriatics or cycloplegics

Landscapes

Health & Medical Sciences (AREA)
Ophthalmology & Optometry (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Cosmetics (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT02795068T 2001-11-21 2002-11-20 Zusammensetzung zur stabilisierung von hyaluronsäure ATE547122T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US33204201P	2001-11-21	2001-11-21
PCT/EP2002/013019 WO2003043660A2 (en)	2001-11-21	2002-11-20	Composition for stabilizing hyaluronic acid

Publications (1)

Publication Number	Publication Date
ATE547122T1 true ATE547122T1 (de)	2012-03-15

Family

ID=23296469

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02795068T ATE547122T1 (de)	2001-11-21	2002-11-20	Zusammensetzung zur stabilisierung von hyaluronsäure

Country Status (8)

Country	Link
US (1)	US20030133986A1 (de)
EP (1)	EP1480677B8 (de)
JP (1)	JP4436131B2 (de)
AT (1)	ATE547122T1 (de)
AU (1)	AU2002360939A1 (de)
CA (1)	CA2458126C (de)
ES (1)	ES2383003T3 (de)
WO (1)	WO2003043660A2 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR059927A1 (es)	2006-03-17	2008-05-07	Johnson & Johnson Vision Care	Metodos para la estabilizacion de composiciones inestables a la oxidacion y composiciones oftalmicas estabilizadas
US8283463B2 (en) *	2010-02-09	2012-10-09	Bausch & Lomb Incorporated	Sterile hyaluronic acid solutions
US8398611B2 (en)	2010-12-28	2013-03-19	Depuy Mitek, Inc.	Compositions and methods for treating joints
US8524662B2 (en)	2010-12-28	2013-09-03	Depuy Mitek, Llc	Compositions and methods for treating joints
US8455436B2 (en)	2010-12-28	2013-06-04	Depuy Mitek, Llc	Compositions and methods for treating joints
US8623839B2 (en) *	2011-06-30	2014-01-07	Depuy Mitek, Llc	Compositions and methods for stabilized polysaccharide formulations
ES2837626T3 (es)	2013-07-10	2021-07-01	Matrix Biology Inst	Composiciones de hialuronano con alta elasticidad y usos de las mismas
US9579257B2 (en)	2013-08-20	2017-02-28	Anutra Medical, Inc.	Haptic feedback and audible output syringe
USD763433S1 (en)	2014-06-06	2016-08-09	Anutra Medical, Inc.	Delivery system cassette
USD750768S1 (en)	2014-06-06	2016-03-01	Anutra Medical, Inc.	Fluid administration syringe
USD774182S1 (en)	2014-06-06	2016-12-13	Anutra Medical, Inc.	Anesthetic delivery device
US20160051723A1 (en) *	2014-08-21	2016-02-25	Gregory J. Pomrink	Bioresorbable tissue repair composition
US9682099B2 (en)	2015-01-20	2017-06-20	DePuy Synthes Products, Inc.	Compositions and methods for treating joints
RU2020123728A (ru) *	2015-09-24	2021-01-18	Матрикс Байолэджи Инститьют	Композиции гиалуроновой кислоты с высокоэластичными свойствами и способы их применения
WO2019191200A1 (en)	2018-03-27	2019-10-03	American Genomics, Llc	Method and formulation for producing anesthesia of internal aspect of eye wall by topical application
DE102018124022A1 (de)	2018-09-28	2020-04-02	Rheinisch-Westfälische Technische Hochschule (Rwth) Aachen	Hyaluronsäurestabilisator
CN114072139A (zh) *	2019-03-26	2022-02-18	马丁·乌拉姆	麻醉组合物和麻醉眼睛的方法
KR20220041136A (ko) *	2019-07-30	2022-03-31	셀릭스 바이오 프라이빗 리미티드	항문 및 직장 질환 치료용 조성물 및 방법
CN111803441A (zh) *	2020-06-10	2020-10-23	西安交通大学医学院第二附属医院	一种含0.01%阿托品的玻璃酸钠滴眼液及其制备方法
WO2025015011A1 (en) *	2023-07-10	2025-01-16	Nevakar Injectables Inc.	Bupivacaine compositions and methods

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5166331A (en) *	1983-10-10	1992-11-24	Fidia, S.P.A.	Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same
US5607698A (en) *	1988-08-04	1997-03-04	Ciba-Geigy Corporation	Method of preserving ophthalmic solution and compositions therefor
US5612027A (en) *	1995-04-18	1997-03-18	Galin; Miles A.	Controlled release of miotic and mydriatic drugs in the anterior chamber
US5683993A (en) *	1995-06-22	1997-11-04	Ciba Vision Corporation	Compositions and methods for stabilizing polymers
EP0938896A1 (de) *	1998-01-15	1999-09-01	Novartis AG	In Autoklaven behandelbare pharmazeutische Zusammensetzungen mit Komplexbildner

2002
- 2002-11-20 CA CA2458126A patent/CA2458126C/en not_active Expired - Fee Related
- 2002-11-20 WO PCT/EP2002/013019 patent/WO2003043660A2/en not_active Ceased
- 2002-11-20 AU AU2002360939A patent/AU2002360939A1/en not_active Abandoned
- 2002-11-20 ES ES02795068T patent/ES2383003T3/es not_active Expired - Lifetime
- 2002-11-20 US US10/300,092 patent/US20030133986A1/en not_active Abandoned
- 2002-11-20 JP JP2003545338A patent/JP4436131B2/ja not_active Expired - Fee Related
- 2002-11-20 AT AT02795068T patent/ATE547122T1/de active
- 2002-11-20 EP EP02795068A patent/EP1480677B8/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
JP4436131B2 (ja)	2010-03-24
WO2003043660A2 (en)	2003-05-30
CA2458126C (en)	2012-06-26
EP1480677B1 (de)	2012-02-29
JP2005509665A (ja)	2005-04-14
US20030133986A1 (en)	2003-07-17
ES2383003T3 (es)	2012-06-15
AU2002360939A8 (en)	2003-06-10
WO2003043660A3 (en)	2003-09-04
EP1480677A2 (de)	2004-12-01
EP1480677B8 (de)	2012-05-23
AU2002360939A1 (en)	2003-06-10
CA2458126A1 (en)	2003-05-30

Similar Documents

Publication	Publication Date	Title
ATE547122T1 (de)	2012-03-15	Zusammensetzung zur stabilisierung von hyaluronsäure
PT833609E (pt)	2002-04-29	Composicoes e processos para estabilizacao de polimeros
DE60110106D1 (de)	2005-05-19	Verfahren zur herstellung von pankreasenzym enthaltende mikrosphären mit hoher stabilität
DE69326352D1 (de)	1999-10-14	Verfahren zur behandlung eines metallischen chirurgischen implantats.
NO20043341L (no)	2004-08-11	Fremgangsmate for fremstilling av scopinestere
AU2003228516A1 (en)	2003-10-27	Occlusive composition comprising a poly (2-cyanoacrylate) monomer
EP2071020A3 (de)	2014-12-31	Gewebeimplantat
ATE388758T1 (de)	2008-03-15	Verfahren zum auflösen lipophiler verbindungen, und kosmetische zusammensetzung.
TW200638946A (en)	2006-11-16	Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins
ATE282317T1 (de)	2004-12-15	Antimikrobielle zusammensetzung zur behandlung von rindermastitis
UA88463C2 (ru)	2009-10-26	Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции
ATE296123T1 (de)	2005-06-15	Verfahren zur herstellung bioaktiver implantatoberflächen
IL152450A (en)	2009-09-01	Compounds and compositions for use in treating tnf-?? mediated conditions
DE602004021501D1 (de)	2009-07-23	Gegenüber ionisierender strahlung stabile polyarylestercarbonatzusammensetzungen
DE69824839D1 (de)	2004-08-05	Verfahren zur herstellung von 2-aryl-3-aryl-5-halogen-pyridinen, verwendbar als cox-2 inhibitoren
ATE383852T1 (de)	2008-02-15	Kupferchelatbildner zur behandlung von augenentzündungen
DK1534352T3 (da)	2008-12-15	Implantat til transport og afgivelse af farmakologisk aktive midler såvel som en fremgangsmåde til fremstilling af samme
ATE346145T1 (de)	2006-12-15	Verfahren zur stabilisierung von thrombin
AU2001250662A1 (en)	2001-10-30	Sequestering
AU3170500A (en)	2000-09-28	Method for preparing an antimicrobial composition
ATE537807T1 (de)	2012-01-15	Dentalimplantat und verfahren zu dessen herstellung
DE60013326D1 (de)	2004-09-30	Verbindungen und verfahren zur behandlung von schmerz
ES2128065T3 (es)	1999-05-01	Composiciones de blanqueo.
DE502004010075D1 (de)	2009-10-29	Verfahren zur herstellung einer festen pharmazeutischen zusammensetzung
PL1716128T3 (pl)	2010-09-30	Podstawione związki 4,5,6,7-tetrahydrobenzotiazol-2-iloaminy